Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin
Sophie Paczesny(MUSC Hollings Cancer Center), James L.M. Ferrara(Tisch Hospital), Stephen H. Olsen(University of Michigan), David A. Hanauer(Associated Press), Jeffrey Crawford(Duke Medical Center), Samir Hanash(The University of Texas MD Anderson Cancer Center), John E. Levine(Icahn School of Medicine at Mount Sinai), Vítor M. Faça(Universidade de Ribeirão Preto), Sung Won Choi(University of Michigan), Shin Mineishi(University of Alabama at Birmingham), Carrie L. Kitko(Vanderbilt University Medical Center), Bryan N. Coffing(University of Michigan), Pavan Reddy(Wichita State University), Gregory A. Yanik(University of Michigan), Ying Wang(Nanjing University), Qing Zhang(Southwestern Medical Center), Hong Wang(The University of Texas MD Anderson Cancer Center), Thomas Braun(University of Michigan), Alice Chin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jason M. Hogan(Fred Hutch Cancer Center), Edward Peres(Henry Ford Hospital), Sharon J. Pitteri(Oregon Health & Science University)
Cited by 250
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945